Pharmacy- Page 182

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)

The FINANCIAL -- Eli Lilly and Company (NYSE: LLY) announced on July 6 it received a fourth approval from the U.S. Food and Drug Administration (FDA) for ALIMTA(R) (pemetrexed for injection).

by The FINANCIAL

July 6, 2009

2 mins read

Pharmacy

Novartis becomes first healthcare company to join United Against Malaria partnership

The FINANCIAL -- On July 6 Novartis announced the delivery of the 250,000,000th treatment of Coartem, a highly-effective artemisinin-based combination therapy (ACT) for the treatment of malaria, with cure rates of more than 95%[2]. To mark this occasion, Dr. Daniel Vasella, Chairman and CEO

by The FINANCIAL

July 6, 2009

1 min read

Pharmacy

Christian Lajoux appointed President for sanofi-aventis in France

The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on June 29 that Christian Lajoux is appointed President for sanofi-aventis in France. He was previously President and General Manager of Pharmaceutical Operations in France.

by The FINANCIAL

June 29, 2009

1 min read

Pharmacy

UCB brings Neupro back to all patients in Europe

The FINANCIAL -- UCB announced on June 29 that Neupro (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic Parkinson's disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in

by The FINANCIAL

June 29, 2009

2 mins read

Pharmacy

Takeda Submitted an Application for an Additional Indication of Alogliptin

The FINANCIAL -- Takeda Pharmaceutical Company Limited (Takeda) on June 29 announced that it submitted an application for an additional indication of alogliptin (generic name, development code: SYR-322) for combination therapy with thiazolidinediones, and a new drug application (NDA) of fixed-dose combination (FDC) of

by The FINANCIAL

June 29, 2009

1 min read

Pharmacy

Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets

The FINANCIAL -- Bayer Schering Pharma AG, Germany, has entered into an exclusive license agreement with Celera Corporation, California, USA, providing Bayer Schering Pharma with access to five cancer-related targets for therapeutic development and in-vivo diagnostic imaging. These therapeutic targets were identified

by The FINANCIAL

June 29, 2009

1 min read

Pharmacy

Merck, Schering-Plough get second FTC request

The FINANCIAL -- Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) on June 22 announced that they each have received a request for additional information from the U.S. Federal Trade Commission (FTC) with respect to their previously announced proposed merger.

by The FINANCIAL

June 22, 2009

1 min read

Pharmacy

GSK announces a strategic alliance with Dr. Reddy’s

The FINANCIAL -- GlaxoSmithKline plc (GSK) on June 15 announced an agreement with Dr. Reddy’s Laboratories Ltd (Dr. Reddy’s) to develop and market selected products across an extensive number of emerging markets, excluding India.

by The FINANCIAL

June 15, 2009

1 min read

Pharmacy

UCB and PatientsLikeMe partner to give people with epilepsy a voice in advancing research

The FINANCIAL -- Biopharma company UCB and PatientsLikeMe, the leading online community for people with life-changing conditions, on June 15 announced a strategic partnership to create an online, open epilepsy community that captures real-world experiences of people living with epilepsy in the U.S.

by The FINANCIAL

June 15, 2009

1 min read

Pharmacy

2-year data show investigational drug liraglutide more effective at lowering blood sugar than glimep

The FINANCIAL -- Data presented on June 7 at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily liraglutide, taken as monotherapy, leads to statistically significant and sustained reductions in blood sugar and weight after two years of treatment.

by The FINANCIAL

June 8, 2009

1 min read